Cited by 111Phase Equilibria and ThermodynamicsProtein purification and stabilityMicroencapsulation and Drying Processes

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Stabilization of Proteins in Dry Powder Formulations Using Supercritical Fluid Technology

Abstract

Therapeutic proteins have become essential in the treatment of many diseases. Their formulation in dry form is often required to improve their stability. Traditional freeze-drying or spray-drying processes are often harmful to labile proteins and could be replaced by supercritical fluid (SCF) drying to produce particles with defined physicochemical characteristics in a mild single step. A survey of the current SCF drying processes for proteins is presented to give insight into the effect of SCF drying on protein stability and to identify issues that need further investigation. Methods used for drying aqueous and organic protein solutions are described. In particular, effects of process and formulation parameters on particle formation and protein stability are discussed. Although SCF methodology for drying proteins is still in its infancy, it can provide a serious alternative to existing drying methods for stabilizing proteins.

Overview

Integrity signals

Registry

Crossref · 10.1023/b:pham.0000048185.09483.e7

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Supercritical drying techniques have been shown to be feasible for other macromolecular biotech products, such as proteins.

    “they have been shown to be feasible –with their pros and cons– for other macromolecular biotech products, such as proteins (Jovanović et al., 2004).”

    From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Jovanović et al., 2004

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 19

  1. M. J. Pikal. Freeze-drying of proteins. Part I: process design. 3(8): 18–27 (1990).
  2. M. J. Pikal. Freeze-drying of proteins. Part II: pormulation selection. 3(9):26–30 (1990).
  3. R. Thiering, F. Dehghani, and N. R. Foster. Micronization of model proteins using compressed carbon dioxide, Proceedings of the 5th International Symposium on Supercritical Fluids, Atlanta, 2000.
  4. N. Elvassore, A. Bertucco, and P. Caliceti. Production of protein-polymer micro-capsules by supercritical anti-solvent techniques, Proceedings of the 5th International Symposium on Supercritical Fluids, Atlanta, 2000.
  5. J. Jung, F. Leboeuf, and M. Perrut. Preparation of inhalable protein particles by SCF-emulsion drying, Proceedings of the 6th International Symposium on Supercritical Fluids, Vol. 3, Versailles, France, 2003, pp. 1837–1842.
  6. D. J. Gilbert, S. Palakodaty, R. Sloan, and P. York. Particle engineering for pharmaceutical applications-A process scale up, Proceedings of the 5th International Symposium on Supercritical Fluids, Atlanta, 2000.
  7. S. Mawson. The formation and characterization of polymeric materials precipitated by CO2-based spray processes (compressed fluid, RESS, PCA, flocculation, carbon dioxide), University of Texas, Austin, TX, 1996, p. 283.
  8. H. C. Pellikaan and F. E. Wubbolts. Nozzle construction for particle formation using supercritical anti solvent precipitation, Proceedings of the 6th International Symposium on Supercritical Fluids, Vol. 3, Versailles, France, 2003, pp. 1765–1770.
  9. N. R. Foster, F. Dehghani, R. T. Bustami, and H.-K. Chan. Generation of lysozyme-lactose powders using the ASES process, Proceedings of the 6th International Symposium on Supercritical Fluids, Vol. 3, Versailles, France, 2003, pp. 1831–1836.
  10. R. E. Sievers, B. A. Miles, S. P. Sellers, P. D. Milewski, and K. D. Kusek. New process for manufacture of 1-micron spherical drug particles by CO2-assisted nebulization of aqueous solutions, Proceedings of Respiratory Drug Delivery VI, South Carolina, 1998, pp. 417–419.
  11. R. E. Sievers, E. T. S. Huang, J. A. Villa, T. R. Walsh, H. V. Meresman, C. D. Liang, and S. P. Cape. Rapid gentle drying using dense carbon dioxide to form fine dry powders, Proceedings of Respiratory Drug Delivery VIII, Tucson, Arizona, 2002, pp. 675–677.
  12. J. W. Mullin. Crystallization, Oxford Butterworth-Heinemann, 1993.
  13. R. T. Bustami and H.-K. Chan. Generation of protein micro-particles using high pressure modified carbon dioxide, Proceedings of the 5th International Symposium on Supercritical Fluids, Atlanta, 2000.
  14. R. T. Forbes, R. Sloan, I. Kibria, M. E. Hollowood, G. O. Humphreys, and P. York. Production of stable protein particles: a comparison of freeze, spray and supercritical drying, Proceedings of the World Congress on Particle Technology 3, Brighton, UK, 1998.
  15. R. Sloan, M. E. Hollowood, G. O. Humphreys, W. Ashraf, and P. York. Supercritical fluid processing: Preparation of stable protein particles, Proceedings of the 5th Meeting on Supercritical Fluids, Nice, France, 1998, pp. 301–306.
  16. R. Thiering, F. Dehghani, A. Dillow, and N. R. Foster. Solvent effects on the controlled dense gas precipitation of model proteins. J. Chem. Technol. Biotechnol. 75:42–53 (2000). · DOI
  17. G. Del Re and G. Di Giacomo. Microparticles production from aqueous solutions using gas antisolvent process, Proceedings of the 8th Meeting on Supercritical Fluids, Bordeaux, France, 2002, pp. 85–90.
  18. M. Sarkari. Solvent engineering of compressed and supercritical fluid solvents for bioprocessing applications, Ph.D. Thesis, University of Kentucky, Lexington, KY, 2000, pp. 192.
  19. R. Sloan, M. Tservistas, M. E. Hollowood, L. Sarup, G. O. Humphreys, P. York, W. Ashraf, and M. Hoare. Controlled particle formation of biological material using supercritical fluids, Proceedings of the 6th Meeting on Supercritical Fluids, Nottingham, UK, 1999, pp. 169-174.

Cited by

Sorted by citations

Metadata

Authors
Jovanović, N., Bouchard, A., Hofland, G. W., Witkamp, G.-J., Crommelin, D. J. A., & Jiskoot, W.
Affiliations
  • Utrecht University (NL)
  • Delft University of Technology (NL)
Corresponding author
Jiskoot, Wim
Venue
Pharmaceutical Research
Published
2004-11
Volume
21
Issue
11
Pages
1955-1969
ISSN
  • 0724-8741 (ISSN-L)
  • 1573-904X
OpenAlex
W2054260828
Cited by
111
References
54
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 4
FWCI
7.45
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmaceutical Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Phase Equilibria and Thermodynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Microencapsulation and Drying Processes
Keywords
supercritical drying, protein stabilization, therapeutic proteins, dry powder formulation, freeze-drying alternative, particle formation, protein stability, formulation parameters
MeSH terms
Carbon Dioxide, Chemistry, Pharmaceutical, Desiccation, Powders, Proteins, Solutions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review